Filing Flows › Cleanspark (CLSK) › Stock forecast & fair value
Cleanspark (CLSK) stock forecast and fair value
Cleanspark (CLSK) trades at $9.22. 15 analysts' median price target is $21.50 (+133%), from $9.50 to $27.00. Across 7 valuation methods the middle fair value is $2.35 (-75%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| Residual income | −$2.21 | −$2.24 | −$2.28 | -124% |
| Analysts' price targets | $9.50 | $20.87 | $27.00 | +126% |
| Shareholder yield (dividends + buybacks) | $5.21 | $5.75 | $6.41 | -38% |
| Tangible book (asset value) | $1.88 | $2.35 | $2.35 | -75% |
| Net cash (floor) | $0.00 | $0.00 | $0.00 | — |
| Stage-weighted value (pre-revenue) | $0.70 | $0.88 | $0.88 | -90% |
| Combined forecast (3 months) | $7.55 | $9.59 | $11.88 | +4% |
Cleanspark's latest quarter
Cleanspark, Q4 FY24: revenue $89.3M (+70% year over year), operating margin -73.5%, net loss $62.1M, operating cash flow −$82.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CLSK stock?
The median of 15 analysts' 12-month targets is $21.50, +133% from $9.22; the range is $9.50 to $27.00. The average rating is strong buy.
What is Cleanspark's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between −$2.24 and $20.87, with a middle value of $2.35 against a price of $9.22. Each method's assumptions are on the page.
Does Cleanspark usually beat earnings estimates?
It beat the consensus EPS estimate in 0% of the quarters on record.
Is CLSK stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.